Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Thematic (Sector/Industry)

<ul><li>The US cannabis MSOS ETF drifted 1.84% lower, while the global YOLO ETF slid 0.54%.</li><li>Absent meaningful news, cannabis stocks are being pressured while we wait for the 60-day comment period on the <span style="font-size: var(--content-font-size);">proposed rule to reschedule cannabis.</span></li><li>Most of the larger MSOs were down last week, with MariMed (CSE: MRMD, OTCQX: MRMD) at -10.46% and Cannabist (NEO: CBST, OTCQX: CBSTF) at -8.06% losing the most. </li></ul>

The US cannabis MSOS ETF drifted 1.84% lower, while the global YOLO ETF slid 0.54%.Absent meaningful news, cannabis stocks are being pressured while we wait for the 60-day comment period on the proposed rule to reschedule cannabis.Most of the larger MSOs were down last week, with MariMed (CSE: MRMD, OTCQX: MRMD) at -10.46% and Cannabist (NEO: CBST, OTCQX: CBSTF) at -8.06% losing the most. 

The Highlights - Cannabis News for the Week Ending May 31, 2024

<ul><li>MSOS fell 14.90% last week, while YOLO dropped 8.72%. Of the larger MSOs, Verano (NEO: VRNO, OTCQX: VRNOF) got hit hardest at -20.77%.</li><li>MariMed (CSE: MRMD, OTCQX: MRMD) at -4.61% and Cannabist (NEO: CBST, OTCQX: CBSTF) at -7.43% held up best, but the entire top 10 was down last week.</li><li>Cannabis stocks continue to sell off in the face ostensibly good news</li></ul>

MSOS fell 14.90% last week, while YOLO dropped 8.72%. Of the larger MSOs, Verano (NEO: VRNO, OTCQX: VRNOF) got hit hardest at -20.77%.MariMed (CSE: MRMD, OTCQX: MRMD) at -4.61% and Cannabist (NEO: CBST, OTCQX: CBSTF) at -7.43% held up best, but the entire top 10 was down last week.Cannabis stocks continue to sell off in the face ostensibly good news

The Highlights - Cannabis News for the Week Ending May 24, 2024

<ul><li>Poseidon co-founders Emily and Morgan Paxhia joined us on the Water Tower Hour podcast to discuss the rescheduling news.</li><li>Those interested can listen to this podcast on Apple Podcasts, Spotify, or on our website.</li><li>On April 30, 2024, the DEA reportedly agreed with the HHS recommendation to reclassify cannabis from Schedule I to Schedule III. </li></ul>

Poseidon co-founders Emily and Morgan Paxhia joined us on the Water Tower Hour podcast to discuss the rescheduling news.Those interested can listen to this podcast on Apple Podcasts, Spotify, or on our website.On April 30, 2024, the DEA reportedly agreed with the HHS recommendation to reclassify cannabis from Schedule I to Schedule III. 

Water Tower Hour Recap - Cannabis Rescheduling Review with Poseidon

<ul><li>This week, the AP reported the DEA has agreed with the HHS recommendation to move cannabis from Schedule I to Schedule III.</li><li>This would remove the 280E tax burden for plant-touching operators, allow for meaningful medical research, and attract new investors.</li><li>The US cannabis MSOS ETF gained 10.14% this week, while the global YOLO ETF climbed 7.67%. </li></ul>

This week, the AP reported the DEA has agreed with the HHS recommendation to move cannabis from Schedule I to Schedule III.This would remove the 280E tax burden for plant-touching operators, allow for meaningful medical research, and attract new investors.The US cannabis MSOS ETF gained 10.14% this week, while the global YOLO ETF climbed 7.67%. 

The Highlights - Cannabis News for the Week Ending May 3, 2024

<ul><li>It was another quiet week across cannabis. The US cannabis MSOS ETF returned 0.23%, while the global YOLO ETF dropped 0.26%.</li><li>While the plant and support for federal reform have never been more popular, real progress continues to be held hostage by politicians.</li><li>While there are reasons to think reform could be imminent, soon, or in the days ahead, investors are becoming impatient with empty promises.</li></ul>

It was another quiet week across cannabis. The US cannabis MSOS ETF returned 0.23%, while the global YOLO ETF dropped 0.26%.While the plant and support for federal reform have never been more popular, real progress continues to be held hostage by politicians.While there are reasons to think reform could be imminent, soon, or in the days ahead, investors are becoming impatient with empty promises.

The Highlights - Cannabis News for the Week Ending April 26, 2024

United States

MariMed, Inc. operates as a pharmaceutical company. The Company specializes in designing, development, operation, funding, and optimization of medical cannabis cultivation, production centers, and dispensaries. MariMed serves customers in the State of Massachusetts.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MariMed (MRMD US)

The Highlights - Cannabis News for the Week Ending May 31, 2024

Most of the larger MSOs were down last week, with MariMed (CSE: MRMD, OTCQX: MRMD) at -10.46% and Cannabist (NEO: CBST, OTCQX: CBSTF) at -8.06%...

Water Tower Research

The Highlights - Cannabis News for the Week Ending May 24, 2024

MSOS fell 14.90% last week, while YOLO dropped 8.72%. Of the larger MSOs, Verano (NEO: VRNO, OTCQX: VRNOF) got hit hardest at -20.77%.

Water Tower Research

Water Tower Hour Recap - Cannabis Rescheduling Review with Poseidon

Poseidon co-founders Emily and Morgan Paxhia joined us on the Water Tower Hour podcast to discuss the rescheduling news.

Water Tower Research

The Highlights - Cannabis News for the Week Ending May 3, 2024

his week, the AP reported the DEA has agreed with the HHS recommendation to move cannabis from Schedule I to Schedule III.

Water Tower Research

The Highlights - Cannabis News for the Week Ending April 26, 2024

While there are reasons to think reform could be imminent, soon, or in the days ahead, investors are becoming impatient with empty promises.

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)